| Overview |
| bsm-90326r-50µL |
| CLPP Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human CLPP |
| 210-277/277 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 8192 |
| Q16740 |
| CLPP; Caseinolytic Mitochondrial Matrix Peptidase Proteolytic Subunit; ATP-Dependent Clp Protease Proteolytic Subunit Mitochondrial; Endopeptidase Clp; EC 3.4.21.92; ClpP (Caseinolytic Protease ATP-Dependent Proteolytic Subunit E. Coli) Homolog; ClpP Caseinolytic Peptidase ATP-Dependent Proteolytic Subunit Homolog (E. Coli); ClpP Caseinolytic Protease ATP-Dependent Proteolytic Subunit Homolog (E. Coli); ClpP Caseinolytic Peptidase ATP-Dependent Proteolytic Subunit Homolog; ClpP Caseinolytic Protease ATP-Dependent Proteolytic Subunit Homolog; Putative ATP-Dependent Clp Protease Proteolytic Subunit Mitochondrial; ATP-Dependent Protease ClpAP (E. Coli) Proteolytic Subunit Human; ClpP Caseinolytic Peptidase ATP-Dependent Proteolytic Subunit; ATP-Dependent; Protease ClpAP Proteolytic Subunit Human; DFNB81; PRLTS3 |
| Cell Line: HeLa Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |